Page last updated: 2024-09-03

mozavaptan and hemicholinium 3

mozavaptan has been researched along with hemicholinium 3 in 1 studies

Compound Research Comparison

Studies
(mozavaptan)
Trials
(mozavaptan)
Recent Studies (post-2010)
(mozavaptan)
Studies
(hemicholinium 3)
Trials
(hemicholinium 3)
Recent Studies (post-2010) (hemicholinium 3)
165824963134

Protein Interaction Comparison

ProteinTaxonomymozavaptan (IC50)hemicholinium 3 (IC50)
Vesicular acetylcholine transporterHomo sapiens (human)0.012

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, K; Egawa, T; Fujii, M; Fujiwara, M; Inada, K; Iwasaki, K; Matsumoto, Y; Mishima, K; Tsukikawa, H1

Other Studies

1 other study(ies) available for mozavaptan and hemicholinium 3

ArticleYear
Ameliorative effect of vasopressin-(4-9) through vasopressin V(1A) receptor on scopolamine-induced impairments of rat spatial memory in the eight-arm radial maze.
    European journal of pharmacology, 2001, Sep-07, Volume: 427, Issue:1

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetylcholine; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium Channel Blockers; Dose-Response Relationship, Drug; Hemicholinium 3; Hippocampus; Hormone Antagonists; Injections, Intraventricular; Male; Maze Learning; Memory; Memory Disorders; Neurotransmitter Uptake Inhibitors; Nicardipine; Peptide Fragments; Pirenzepine; Rats; Rats, Wistar; Receptors, Vasopressin; Scopolamine

2001